The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Concordance study of HER2 fluorescence in situ hybridization (FISH) assays in upper gastrointestinal (UGI) adenocarcinomas.
Michael F. Press
Consultant or Advisory Role - GlaxoSmithKline; Merrimack Pharmaceuticals
Honoraria - GlaxoSmithKline
Tobias Grob
Consultant or Advisory Role - Abbott Laboratories; GlaxoSmithKline
Andreas Marx
No relevant relationships to disclose
Ivonne Villalobos
Consultant or Advisory Role - GlaxoSmithKline; Merrimack Pharmaceuticals
Honoraria - GlaxoSmithKline
Angela Santiago
No relevant relationships to disclose
Roberta Guzman
No relevant relationships to disclose
Robert C. Gagnon
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Carmen Arenas-Elliott
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Catherine Elizabeth Ellis
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline